NEW
Stock Screener with Intrinsic Value
Protagonist Therapeutics, Inc. (PTGX)
Last Price$37.2(1.6%)
Market Cap$2,297.8M
N/A
Peers median - 15.7%
70.8%
Peers median - 12.6%
2.0%
Peers median - 10.1%
1,393.1%
Peers median - (28.7%)
Competing with PTGX
Overview
Ratings
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Compare PTGX Valuation Multiples with Peers
Crunching data... Almost there!
Compare PTGX Valuation Multiples Dynamics with Peers
Crunching data... Almost there!
FAQ
1. How does Protagonist Therapeutics, Inc. (PTGX) revenue growth compare to peers and the industry?
Protagonist Therapeutics, Inc. (PTGX) revenue growth is N/A, compared to the peers' median of 15.7%.
2. How does Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) margin compare to peers and the industry?
Protagonist Therapeutics, Inc. (PTGX) FCF margin is 70.8%, compared to the peers' median of 12.6%.
3. How does Protagonist Therapeutics, Inc. (PTGX) Total Debt to Equity ratio compare to peers and the industry?
Protagonist Therapeutics, Inc. (PTGX) Total Debt to Equity ratio is 2.0%, compared to the peers' median of 10.1%.
4. How does Protagonist Therapeutics, Inc. (PTGX) ROIC (Return on Invested Capital) compare to peers and the industry?
Protagonist Therapeutics, Inc. (PTGX) ROIC is 1,393.1%, compared to the peers' median of (28.7%).